During the past decade, Peter MacCallum Cancer Centre; Medical Oncology conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peter MacCallum Cancer Centre; Medical Oncology" #1 collaborator was "Genentech, Inc." with 4 trials as a collaborator, "BioLineRx, Ltd." with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Peter MacCallum Cancer Centre; Medical Oncology" are "Breast Cancer" (6 trials), "Solid Tumors" (4 trials), "Malignant Melanoma" (3 trials), "Non-Small Cell Lung Cancer" (2 trials) and "Triple Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Peter MacCallum Cancer Centre; Medical Oncology" in a lesser frequency.

Most popular intervention types in "Peter MacCallum Cancer Centre; Medical Oncology" are "Drug" (25 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (7 trials), "Placebo" (6 trials), "Paclitaxel" (4 trials), "Cobimetinib" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Peter MacCallum Cancer Centre; Medical Oncology" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Peter MacCallum Cancer Centre; Medical Oncology". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Peter MacCallum Cancer Centre; Medical Oncology, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Peter MacCallum Cancer Centre; Medical Oncology, 8 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".